Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
, /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has completed the…
Medical 21, Inc. Announces Regulatory Approval to Initiate First-in-Human Clinical Study in Spain
Regulatory clearance enables launch of the MAVERICS Coronary Revascularization Study, advancing evaluation of the Company’s next-generation synthetic small-diameter bypass graft. , /PRNewswire/ — Medical 21, Inc., a private medical technology…
ORYZON Announces the Voting Results of December 2025 Extraordinary General Shareholders’ Meeting
37.8% of voting rights present or represented All resolutions were approved MADRID and CAMBRIDGE, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage…
Jeonbuk National University Researchers Explore the Impact of Different Seasonings on the Flavor Perception of Doenjang Soup
Researchers examine how different seasonings shape kokumi perception in doenjang soup and influence consumer acceptance , /PRNewswire/ — Doenjang is a traditional Korean fermented soybean paste made from meju—naturally fermented…
Chonnam National University Uncovers a New Molecular Target of Obesity
Researchers identify RFP protein as a key driver of fat cell formation, opening paths to future obesity treatments , /PRNewswire/ — Obesity is excessive fat accumulation. Despite decades of research,…
Leucid Bio and Syenex Announce Strategic Collaboration for In Vivo CAR-T Cell Engineering
Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTM , /PRNewswire/ — Leucid Bio (“Leucid” or the “Company”), a privately-held biotechnology company developing innovative Chimeric Antigen Receptor T-cell (CAR-T)…
OKYO Pharma Announces Chairman and Founder Acquires Shares
LONDON and NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an…
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
TORONTO, Dec. 15, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel…
ALZpath and Siemens Healthineers Sign Licensing Agreement to Advance Global Access to Blood-Based Alzheimer’s Disease Diagnostic Testing
Siemens Healthineers will utilize ALZpath’s high-performing, proprietary pTau217 antibody in its growing test menu for its Atellica analyzers to enable IVD testing for Alzheimer’s disease , /PRNewswire/ — ALZpath, Inc.,…
Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors
Closes $60 Million Series A Financing Round Backed by New and Existing Investors $92 Million Raised to Date Across Seed and Series A Financings , /PRNewswire/ — Link Cell Therapies…